Ginkgo Bioworks Holdings, Inc. — Investor Relations & Filings
Ginkgo Bioworks Holdings, Inc. operates a horizontal platform for cell programming and synthetic biology. The company utilizes advanced automation, proprietary software, and data analytics in its biofoundries to design, build, and test engineered organisms for its partners. The platform's goal is to make programming cells as accessible as programming computers, thereby accelerating biotechnology research and development. Ginkgo serves a broad range of markets, including biopharmaceuticals, agriculture, food and nutrition, and industrial chemicals. Its services support the development of products such as novel therapeutics, sustainable agricultural solutions, and specialty ingredients. Additionally, the company provides biosecurity services for pathogen detection and public health response.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer) | 2026-04-29 | English | |
| 8-K - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer) | 2026-04-07 | English | |
| 8-K - GINKGO BIOWORKS HOLDINGS, INC. (0001830214) (Filer) | 2026-02-26 | English | |
| 10-K - GINKGO BIOWORKS HOLDINGS, INC. (0001830214) (Filer) | 2026-02-26 | English | |
| 8-K - GINKGO BIOWORKS HOLDINGS, INC. (0001830214) (Filer) | 2026-02-26 | English | |
| SCHEDULE 13G/A Filing | 2026-02-05 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 38812609 | DEF 14A - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer) | 2026-04-29 | English | ||
| 33748028 | 8-K - Ginkgo Bioworks Holdings, Inc. (0001830214) (Filer) | 2026-04-07 | English | ||
| 32899355 | 8-K - GINKGO BIOWORKS HOLDINGS, INC. (0001830214) (Filer) | 2026-02-26 | English | ||
| 32899356 | 10-K - GINKGO BIOWORKS HOLDINGS, INC. (0001830214) (Filer) | 2026-02-26 | English | ||
| 32899354 | 8-K - GINKGO BIOWORKS HOLDINGS, INC. (0001830214) (Filer) | 2026-02-26 | English | ||
| 31961524 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 13333861 | FORM 4 | 2026-01-22 | English | ||
| 13333863 | Regulatory Filings 2026 | 2026-01-20 | English | ||
| 13333862 | Regulatory Filings 2026 | 2026-01-07 | English | ||
|
2025
6 filings
| |||||
| 13333864 | 8-K | 2025-12-23 | English | ||
| 13333865 | FORM 4 | 2025-12-16 | English | ||
| 13333866 | Regulatory Filings 2025 | 2025-12-15 | English | ||
| 13333867 | Regulatory Filings 2025 | 2025-12-10 | English | ||
| 13333868 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13333870 | Regulatory Filings 2025 | 2025-11-12 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Ginkgo Bioworks Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32424/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32424 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32424 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32424 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32424}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ginkgo Bioworks Holdings, Inc. (id: 32424)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.